Pfizer booster provides significant protection against Omicron variant – study – The Irish Times

Sign up for alerts from The Irish Times
Just click on “Allow Notifications” on the message appearing on your browser to activate them.
We will send you a quick reminder in the future, in case you change your mind.



The findings were similar to those presented by BioNTech and Pfizer earlier in the week, which were an early signal that booster shots could be key to protect against infection from the newly identified variant. Photograph: Daniel Leal/AFP via Getty
Israeli researchers said on Saturday they found that a three-shot course of the Pfizer/BioNTech Covid-19 vaccine provided significant protection against the new Omicron variant.
The findings were similar to those presented by BioNTech and Pfizer earlier in the week, which were an early signal that booster shots could be key to protect against infection from the newly identified variant.
The study, carried out by Sheba Medical Centre and the health ministry’s Central Virology Laboratory, compared the blood of 20 people who had received two vaccine doses five to six months earlier to the same number of individuals who had received a booster a month before.
“People who received the second dose five or six months ago do not have any neutralisation ability against the Omicron. While they do have some against the Delta [strain],” Gili Regev-Yochay, director of the Infectious Diseases Unit at Sheba, told reporters.
“The good news is that with the booster dose it increases about a hundred fold. There is a significant protection of the booster dose. It is lower than the neutralization ability against the Delta, about four times lower,” she said.
The Israeli team said they worked with the actual virus while the companies used what is known as a pseudovirus, which was bio-engineered to have the hallmark mutations of Omicron.
The Israeli research follows a study from South Africa that found the Omicron variant can partially evade protection from two doses. – Reuters
Everything you need to know about the Covid-19 outbreak
 Subscribe.
Daily
Stay on top of the latest news with our daily newsletters each morning, lunchtime and evening
Sign up
Subscribe
Support
Irish Times products & services
About us
Our partners




Invalid email or password.
Unfortunately USERNAME we were unable to process your last payment. Please update your payment details to keep enjoying your Irish Times subscription.

source


0Shares

Add a Comment

Your email address will not be published.